SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3561 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1535Very good CC, I like the optimism on Arcalyst and 475. I continue to believe thaMiljenko Zuanic-4/26/2012
1534WOW!Miljenko Zuanic-4/26/2012
1533Wow, here is the PR and the numbers. I was a bit low on my EYLEA estimates: inBiotech Jim-4/26/2012
1532Any number around 80M (+/- 5%) is a good one. It will be an interesting CC, to hMiljenko Zuanic-4/25/2012
1531I am going with $82M for Eyelea sales this quarter and $380-420M in sales for thBiotech Jim-4/25/2012
1530Maybe good! What do you expect? $80M in Eylea sale? Less, more?Miljenko Zuanic-4/24/2012
1529How will this affect Eylea? Seems recent ER reports state that there Lucentis/AFelix B-4/23/2012
1528CATT live: prolibraries.comMiljenko Zuanic-4/18/2012
1527RE: Arcalyst Never thought that "Old drug" Colchicine (COLCRYS, URL Miljenko Zuanic-4/11/2012
1526My view is: CRVO>gout>mCRC. I would say that CRVO is pretty much a locBiotech Jim14/6/2012
1525Another example, Sanofi (REGN) want as to believe that there is no safety issuMiljenko Zuanic14/6/2012
1524What are the chances it passes? I think between gout and CRVO, CRVO has the besFelix B-4/5/2012
1523Jim, In 2007/8/9 Sanovi had more Avastin + Sanofi drug PII trials ongoing (Oxa Miljenko Zuanic14/5/2012
1522Agree that it was expected. But, I would guess that SNY had a check the box rouBiotech Jim-4/5/2012
1521finance.yahoo.com More or less, it was expected...Trap does not work for metastMiljenko Zuanic-4/5/2012
1520From REGN IR, study 11565 reported in the latest (03-29) Journal of the AmericalMiljenko Zuanic-3/29/2012
1519Me too, it was oral presentation with slides, so we should be able to get them. Miljenko Zuanic-3/27/2012
1518Unfortunately I have not seen any of the data presented at the ACC, as I am not Biotech Jim-3/27/2012
1517At this point it is worthless to compare AMG145 vs. REGN727. 145 may have 4w regMiljenko Zuanic-3/26/2012
1516Anyone want to give us an assessment of the Amgen drug vs. the Regeneron one?Chris08-3/26/2012
1515Jim, do you have data per groups/doses for trial-11565?Miljenko Zuanic-3/26/2012
1514Here is the data set etc... multivu.comBiotech Jim-3/26/2012
1513AMG145 results (1b) looks very good. finance.yahoo.comMiljenko Zuanic13/25/2012
1512Late Breaking clinical abstracts/presentations at the ongoing ACC meeting in ChiBiotech Jim-3/24/2012
1511Hi Jim, On many points agree with you. My (additional) reasoning to continue wiMiljenko Zuanic-3/14/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News